{
 "drug": "Fluphenazine Hydrochloride Tablet",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "09/18/2025",
 "dayN": 341,
 "cat": "Neurology",
 "companies": [
  "Upsher-Smith Laboratories, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "09/18/2025",
   "update_type": "New",
   "initial_posting_date": "09/18/2025",
   "package_ndc": "0832-6003-11",
   "generic_name": "Fluphenazine Hydrochloride Tablet",
   "contact_info": "763-315-2000",
   "related_info": "Discontinuation of the manufacture of the drug.",
   "openfda": {
    "application_number": [
     "ANDA213784"
    ],
    "brand_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Upsher-Smith Laboratories,LLC"
    ],
    "product_ndc": [
     "0832-6003",
     "0832-6004",
     "0832-6005",
     "0832-6006"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "859841",
     "860918",
     "865117",
     "865123"
    ],
    "spl_id": [
     "3bb74f82-8872-9829-e063-6294a90aeace"
    ],
    "spl_set_id": [
     "f07bb3f1-c68c-441b-9de4-99a219f2500a"
    ],
    "package_ndc": [
     "0832-6004-11",
     "0832-6003-11",
     "0832-6005-11",
     "0832-6006-11"
    ],
    "unii": [
     "ZOU145W1XL"
    ]
   },
   "update_date": "09/18/2025",
   "therapeutic_category": [
    "Neurology",
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Fluphenazine Hydrochloride, Tablet, 1 mg (NDC 0832-6003-11)",
   "company_name": "Upsher-Smith Laboratories, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "09/18/2025",
   "update_type": "New",
   "initial_posting_date": "09/18/2025",
   "package_ndc": "0832-6005-11",
   "generic_name": "Fluphenazine Hydrochloride Tablet",
   "contact_info": "763-315-2000",
   "related_info": "Discontinuation of the manufacture of the drug.",
   "openfda": {
    "application_number": [
     "ANDA213784"
    ],
    "brand_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Upsher-Smith Laboratories,LLC"
    ],
    "product_ndc": [
     "0832-6005",
     "0832-6004",
     "0832-6003",
     "0832-6006"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "859841",
     "860918",
     "865117",
     "865123"
    ],
    "spl_id": [
     "3bb74f82-8872-9829-e063-6294a90aeace"
    ],
    "spl_set_id": [
     "f07bb3f1-c68c-441b-9de4-99a219f2500a"
    ],
    "package_ndc": [
     "0832-6004-11",
     "0832-6003-11",
     "0832-6005-11",
     "0832-6006-11"
    ],
    "unii": [
     "ZOU145W1XL"
    ]
   },
   "update_date": "09/18/2025",
   "therapeutic_category": [
    "Neurology",
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Fluphenazine Hydrochloride, Tablet, 5 mg (NDC 0832-6005-11)",
   "company_name": "Upsher-Smith Laboratories, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "09/18/2025",
   "update_type": "New",
   "initial_posting_date": "09/18/2025",
   "package_ndc": "0832-6004-11",
   "generic_name": "Fluphenazine Hydrochloride Tablet",
   "contact_info": "763-315-2000",
   "related_info": "Discontinuation of the manufacture of the drug.",
   "openfda": {
    "application_number": [
     "ANDA213784"
    ],
    "brand_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Upsher-Smith Laboratories,LLC"
    ],
    "product_ndc": [
     "0832-6004",
     "0832-6003",
     "0832-6005",
     "0832-6006"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "859841",
     "860918",
     "865117",
     "865123"
    ],
    "spl_id": [
     "3bb74f82-8872-9829-e063-6294a90aeace"
    ],
    "spl_set_id": [
     "f07bb3f1-c68c-441b-9de4-99a219f2500a"
    ],
    "package_ndc": [
     "0832-6004-11",
     "0832-6003-11",
     "0832-6005-11",
     "0832-6006-11"
    ],
    "unii": [
     "ZOU145W1XL"
    ]
   },
   "update_date": "09/18/2025",
   "therapeutic_category": [
    "Neurology",
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Fluphenazine Hydrochloride, Tablet, 2.5 mg (NDC 0832-6004-11)",
   "company_name": "Upsher-Smith Laboratories, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "09/18/2025",
   "update_type": "New",
   "initial_posting_date": "09/18/2025",
   "package_ndc": "0832-6006-11",
   "generic_name": "Fluphenazine Hydrochloride Tablet",
   "contact_info": "763-315-2000",
   "related_info": "Discontinuation of the manufacture of the drug.",
   "openfda": {
    "application_number": [
     "ANDA213784"
    ],
    "brand_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Upsher-Smith Laboratories,LLC"
    ],
    "product_ndc": [
     "0832-6006",
     "0832-6004",
     "0832-6003",
     "0832-6005"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "FLUPHENAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "859841",
     "860918",
     "865117",
     "865123"
    ],
    "spl_id": [
     "3bb74f82-8872-9829-e063-6294a90aeace"
    ],
    "spl_set_id": [
     "f07bb3f1-c68c-441b-9de4-99a219f2500a"
    ],
    "package_ndc": [
     "0832-6004-11",
     "0832-6003-11",
     "0832-6005-11",
     "0832-6006-11"
    ],
    "unii": [
     "ZOU145W1XL"
    ]
   },
   "update_date": "09/18/2025",
   "therapeutic_category": [
    "Neurology",
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Fluphenazine Hydrochloride, Tablet, 10 mg (NDC 0832-6006-11)",
   "company_name": "Upsher-Smith Laboratories, LLC",
   "status": "To Be Discontinued"
  }
 ]
}